GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: AVE-4221 | AVE4221 | compound 1 [PMID: 23968485] | NXL-101 | NXL101
Compound class:
Synthetic organic
Comment: Viquidacin acts as an inhibitor of bacterial topoisomerase IV and DNA gyrase [1].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| (3R,4R)-4-[(3S)-3-(3-fluoro-6-methoxyquinolin-4-yl)-3-hydroxypropyl]-1-(2-thiophen-2-ylsulfanylethyl)piperidine-3-carboxylic acid |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 8971 | viquidacin |
Synonyms ![]() |
| AVE-4221 | AVE4221 | compound 1 [PMID: 23968485] | NXL-101 | NXL101 |
Database Links ![]() |
|
| Specialist databases | |
Antibiotic DB
|
NXL101 |
| Other databases | |
| BindingDB Ligand | 50393503 |
| CAS Registry No. | 904302-98-3 (source: WHO INN record) |
| ChEMBL Ligand | CHEMBL2158050 |
| GtoPdb PubChem SID | 405560313 |
| PubChem CID | 11591505 |
| Search Google for chemical match using the InChIKey | USGHRRVFKSLEJT-WVBUVRCRSA-N |
| Search Google for chemicals with the same backbone | USGHRRVFKSLEJT |
| Search PubMed clinical trials | viquidacin |
| Search PubMed titles | viquidacin |
| Search PubMed titles/abstracts | viquidacin |
| UniChem Compound Search for chemical match using the InChIKey | USGHRRVFKSLEJT-WVBUVRCRSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | USGHRRVFKSLEJT-WVBUVRCRSA-N |